Dr. Mitchell H. Finer, Ph.D. is Founder, Senior Consultant and Member of Scientific Advisory Board at Avalanche Biotechnologies, Inc. Dr. Finer had served as chief scientific officer of Bluebird Bio from March 2010 to July 2015.Prior to joining Bluebird, Dr. Finer served as senior vice president of development and operations for Novocell, Inc. (now ViaCyte, Inc.), a stem cell engineering company researching treatments for diabetes and other chronic diseases, from 2008 through March 2010.
Dr. Finer served as chief executive officer of Intracel Holdings LLC from 2005 through November 2008. From 2003 to 2005, Dr. Finer was President and Chief Executive Officer of Genteric Inc., or Genteric, where he had been Chief Scientific Officer. His past experience included vice president of research and development for the Gencell division of Aventis Pharma (now Sanofi) and vice president of research for Cell Genesys Inc., and a founder of Abgenix, Inc.
Dr. Finer received his B.A. in biochemistry and bacteriology from the University of California at Berkeley and his Ph.D. in biochemistry and molecular biology from Harvard University. He completed a postdoctoral fellowship at the Whitehead Institute for Biomedical Research.